They found that p38 MAPK activity was significantly attenuated in hepatocytes with TIPE2-overexpression, leading to protective effects against non-alcoholic fatty liver disease (NAFLD) [28]. This evidence concerns the gene TIPE2 and metabolic dysfunction-associated steatotic liver disease.